Prescription drug · ANDA
Brivaracetam NDC 60505-4727
Brivaracetam 100 mg/1 · Tablet · Oral · Apotex Corp.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60505-4727-6 | 60505472706 | 60 TABLET in 1 BOTTLE (60505-4727-6)Marketed from Feb 24, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Apotex Corp.NDC labeler code 60505
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214875
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 60505-4727_a2119162-90a5-0d0c-9d3b-6364bf087960SPL ID a2119162-90a5-0d0c-9d3b-6364bf087960SPL set ID 1915620d-4f37-56c2-437e-8362bb462d07RxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0360505472666, 0360505472468, 0360505472765, 0360505472567
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460505472706followed by a unit qualifier and the quantityPackage 60505-4727-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 60505-4727
- What is NDC 60505-4727?
- 60505-4727 is the product NDC for Brivaracetam, Brivaracetam 100 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Brivaracetam.
- What is the active ingredient?
- Brivaracetam.
- Who is the labeler?
- Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Brivaracetam?
- 52 other product NDCs are listed under this name. See all Brivaracetam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Brivaracetam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brivaracetam | Brivaracetam 10 mg/mL | SolutionOral | Aurobindo Pharma Limited | 59651-995 | 59651-0995-03 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-823 | 76282-0823-60 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-822 | 76282-0822-60 |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-824 | 76282-0824-60 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-825 | 76282-0825-60 |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-826 | 76282-0826-60 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-068 | 84386-0068-60 |
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-069 | 84386-0069-60 |
| Brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-071 | 84386-0071-60 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-074 | 73190-0074-60 |
Other NDCs under ANDA 214875
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Brivaracetam | Brivaracetam 10 mg/1 | TabletOral | Apotex Corp. | 60505-4723 |
| Brivaracetam | Brivaracetam 25 mg/1 | TabletOral | Apotex Corp. | 60505-4724 |
| Brivaracetam | Brivaracetam 50 mg/1 | TabletOral | Apotex Corp. | 60505-4725 |
| Brivaracetam | Brivaracetam 75 mg/1 | TabletOral | Apotex Corp. | 60505-4726 |